FDA Inspection
Kindeva Drug Delivery LPKindeva Drug Delivery LP – FDA Inspection, Nov 13, 2025
Record Details
This FDA Inspection record concerns Kindeva Drug Delivery LP, with an inspection on November 13, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · b37641bf-e88e-489b-abd5-0192feee2887
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1286864
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kindeva Drug Delivery LP
11| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 6, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 1, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kindeva Drug Delivery LP
- FDA Inspection 1151074 - 2021-07-28
- FDA Inspection 1082205 - 2019-01-25
- FDA Inspection 1077108 - 2019-01-25
- FDA Inspection 1008836 - 2017-03-06
- FDA Inspection 940328 - 2015-09-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.